Bladder Cancer

Cancer Epidemiology and Prevention

Volumn , Issue , 2009, Pages

  Silverman, Debra T ^a   Devesa, Susan S ^a   Moore, Lee E ^a   Rothman, Nathaniel ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Bladder; Cancer epidemiology; Cancer prevention; Cancer risk

Indexed keywords

EID: 84920113349     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1093/acprof:oso/9780195149616.003.0058     Document Type: Chapter

References (533)

1. Aben KK, Witjes JA, Schoenberg MP, et al. 2002. Familial aggregation of urothelial cell carcinoma. Int J Cancer 98:274-278.
2. Abdel Mohsen MA, Hassan AA, El Sewedy SM, et al. 1999. Biomonitoring of n-nitroso compounds, nitrite and nitrate in the urine of Egyptian bladder cancer patients with or without Schistosoma haematobium infection. Int J Cancer 82:789-794.
3. Airoldi L, Orsi F, Magagnotti C, Coda R, et al. 2002. Determinants of 4-aminobiphenyl-DNA adducts in bladder cancer biopsies. Carcinogenesis 23:861-866.
4. Alderson M. 1986. Occupational Cancer. London: Butterworth and Co. Ltd.
5. Alguacil J, Kogevinas M, Silverman DT, et al. 2003. Urine pH and bladder cancer risk in the Spanish Bladder Cancer Study. AACR special conference on Molecular and Genetic Epidemiology. Waikoloa, Hawaii. Proceedings of the American Association for Cancer Research. Proceedings of the Molecular and Genetic Epidemiology of Cancer Conference. B52.
6. American Joint Committee on Cancer. 1988. Manual for staging of cancer. Philadelphia: Lippincott.
7. Andrew AS, Schned AR, Heaney JA, Karagas MR. 2004. Bladder cancer risk and personal hair dye use. Int J Cancer 109:581-586.
8. Antony HM. 1974. Industrial exposure in patients with carcinoma of the bladder. J Soc Occup Med 24:110.
9. Anwar WA, Abdel-Rahman SZ, El Zein RA, et al. 1996. Genetic polymorphism of GSTM1, CYP2E1 and CYP2D6 in Egyptian bladder cancer patients. Carcinogenesis 17:1923-1929.
10. Armstrong B, Doll R. 1974. Bladder cancer mortality in England and Wales in relation to cigarette smoking and saccharin consumption. Br J Prev Soc Med 28:233-240.
11. Armstrong B, Doll R. 1975. Bladder cancer mortality in diabetics in relation to saccharin consumption and smoking habits. Br J Prev Soc Med 29:73-81.
12. Augustine A, Hebert JR, Kabat GC, et al. 1988. Bladder cancer in relation to cigarette smoking. Cancer Res 48:4405-4408.
13. Augustsson K, Skog K, Jagerstad M, et al. 1999. Dietary heterocyclic amines and cancer of the colon, rectum, bladder, and kidney: a population-based study. Lancet 353:703-707.
14. Babu SR, Lakshmi VM, Hsu FF, et al. 1993. N-acetylbenzidine-N'-glucuronidation by human, dog and rat liver. Carcinogenesis 14:2605-2611.
15. Babu SR, Lakshmi VM, Hsu FF, et al. 1992. Role of N-glucuronidation in benzidine-induced bladder cancer in dog. Carcinogenesis 13:1235-1240.
16. Babu SR, Lakshmi VM, Huang GP, et al. 1996. Glucuronide conjugates of 4-aminobiphenyl and its N-hydroxy metabolites. pH stability and synthesis by human and dog liver. Biochem Pharmacol 51:1679-1685.
17. Badawi AF, Mostafa MH, Probert A, et al. 1995. Role of schistosomiasis in human bladder cancer: evidence of association, aetiological factors, and basic mechanisms of carcinogenesis. Eur J Cancer Prev 4:45-59.
18. Balbi JC, Larrinaga MT, De Stefani E, et al. 2001. Foods and risk of bladder cancer: a case-control study in Uruguay. Eur J Cancer Prev 10:453-458.
19. Barbone F, Franceschi S, Talamini R, et al. 1994. Occupation and bladder cancer in Pordenone north-east Italy: a case-control study. Int J Epidemiol 23:58-65.
20. Bartsch H. 1991. N-Nitroso compounds and human cancer: where do we stand? Lyon: International Agency for Research on Cancer 1-10.
21. Bartsch H, Malaveille c, Friesen M, et al. 1993. Black air cured. and blond flue cured. tobacco cancer risk. IV: Molecular dosimetry studies implicate aromatic amines as bladder carcinogens. Eur J Cancer 29A:1199-1207.
22. Bates MN, Smith AH, Cantor KB. 1995. Case-control study of bladder cancer and arsenic in drinking water. Am J Epidemiol 141:523-530.
23. Bates MN, Rey OA, Biggs ML, et al. 2004. Case-control study of bladder cancer and exposure to arsenic in Argentina. Am J Epidemiol 159:381-389.
24. Baus Subcommittee on Industrial Bladder Cancer. 1988. Occupational bladder cancer: a guide for clinicians. The BAUS Subcommittee on Industrial Bladder Cancer. Br J Urol 61:183-191.
25. Baxter P, McDowall ME. 1986. Occupation and cancer in London: an investigation into nasal and bladder cancer using the Cancer Atlas. Br J Ind Med 43:44-49.
26. Bedwani R, Renganathan E, El Kwhsky F, et al. 1998. Schistosomiasis and the risk of bladder cancer in Alexandria, Egypt. Br J Cancer 77:1186-1189.
27. Bell DA, Taylor JA, Paulson DF. 1993. Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J Natl Cancer Inst 85:1159-1164.
28. Bethwaite PB, Pearce N, Fraser J. 1990. Cancer risks in painters: study based on the New Zealand Cancer Registry. Br J Ind Med 47:742-746.
29. Bhagwandeen SB. 1976. Schistosomiasis and carcinoma of the bladder in Zambia. S Afr Med J 50:1616-1620.
30. Bi W, Hayes RB, Feng P, et al. 1992. Mortality and incidence of bladder cancer in benzidine-exposed workers in China. Am J Ind Med 21:481-489.
31. Blot WJ, Fraumeni JF Jr. 1978. Geographic patterns of bladder cancer in the United States. J Natl Cancer Inst 61:1017-1023.
32. Blum M, Demierre A, Grant DM, et al. 1991. Molecular mechanism of slow acetylation of drugs and carcinogens in humans. Proc Natl Acad Sci U S A 88:5237-5241.
33. Boffetta P, Silverman DT. 2001. A meta-analysis of bladder cancer and diesel exhaust exposure. Epidemiology 12:125-130.
34. Boice JD Jr., Engholm G, Kleinerman RA, et al. 1988. Radiation dose and second cancer risk in patients treated for cancer of the cervix. Radiat Res 116:3-55.
35. Boyko RW, Cartwright RA, Glashan RW. 1985. Bladder cancer in dye manufacturing workers. J Occup Med 27:799-803.
36. Braver DJ, Modan M, Chetrit A, et al. 1987. Drinking, micturition habits, and urine concentration as potential risk factors in urinary bladder cancer. J Natl Cancer Inst 78:437-440.
37. Brennan P, Bogillot O, Cordier S, et al. 2000. Cigarette smoking and bladder cancer in men: a pooled analysis of 11 case-control studies. Int J Cancer 86:289-294.
38. Bringuier PP, Tamimi Y, Schuuring E, et al. 1996. Expression of cyclin D1 and EMS1 in bladder tumours; relationship with chromosome 11q13 amplification. Oncogene 12:1747-1753.
39. Broberg K, Bjork J, Paulsson K, et al. 2005. Constitutional short telomeres are strong genetic susceptibility markers for bladder cancer. Carcinogenesis 26:1263-1271.
40. Brockmoller J, Cascorbi I, Kerb R, et al. 1996. Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione Stransferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk. Cancer Res 56:3915-3925.
41. Bross ID, Tidings J. 1973. Another look at coffee drinking and cancer of the urinary bladder. Prev Med 2:445-451.
42. Brown LM, Zahm SH, Hoover RN, et al. 1995. High bladder cancer mortality in rural New England, United States: an etiologic study. Cancer Causes Control 6:361-368.
43. Brownson RC, Chang JC, Davis JR. 1987. Occupation, smoking, and alcohol in the epidemiology of bladder cancer. Am J Public Health 77:1298-1300.
44. Bruemmer B, White E, Vaughan TL, et al. 1997. Fluid intake and the incidence of bladder cancer among middle-aged men and women in a three-county area of western Washington. Nutr Cancer 29:163-168.
45. Bruemmer B, White E, Vaughan TL, et al. 1996. Nutrient intake in relation to bladder cancer among middle-aged men and women. Am J Epidemiol 144:485-495.
46. Bryant MS, Vineis P, Skipper PL, et al. 1988. Hemoglobin adducts of aromatic amines: associations with smoking status and type of tobacco. Proc Natl Acad Sci U S A 85:9788-9791.
47. Burch JD, Rohan TE, Howe GR, et al. 1989. Risk of bladder cancer by source and type of tobacco exposure: a case-control study. Int J Cancer 44:622-628.
48. Butler MA, Lang NP, Young JF, et al. 1992. Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolites. Pharmacogenetics 2:116-127.
49. CancerNet PDQ. 2003. Screening for Bladder Cancer (PDQ); Screening/Detection: Health Professionals. Bethesda, Md: CancerNet PDQ, NCI. Available at: http://cancernet.nci.nih.gov.
50. Cantor KP. 2001. Invited commentary: arsenic and cancer of the urinary tract. Am J Epidemiol 153:422-423.
51. Cantor KP. 1997. Drinking water and cancer. Cancer Causes Control 8:292-308.
52. Cantor KP, Hoover R, Hartge P, et al. 1987. Bladder cancer, drinking water source, and tap water consumption: a case-control study. J Natl Cancer Inst 79:1269-1279.
53. Cantor KP, Lynch CF, Hildesheim ME, et al. 1998. Drinking water source and chlorination byproducts. I. Risk of bladder cancer. Epidemiology 9:21-28.
54. Cappellen D, De Oliveira C, Ricol D, et al. 1999. Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas. Nat Genet 23:18-20.
55. Cardis E, Gilbert E, Carpenter L, et al. 1995. Effects of Low Doses and Low Dose Rates of External Ionizing Raidation: Cancer Mortality among Nuclear Industry Workers in Three Countries. Radiat Res 142:117-132.
56. Carreon T, Ruder AM, Schulte PA, et al. 2006. NAT2 slow acetylation and bladder cancer in workers exposed to benzidine. Int J Cancer 118:161-168.
57. Cartwright RA. 1979a. Genetic association with bladder cancer. Br Med J 2:798.
58. Cartwright RA, Adib R, Appleyard I, et al. 1983. Cigarette smoking and bladder cancer: an epidemiological inquiry in West Yorkshire. J Epidemiol Community Health 37:256-263.
59. Cartwright RA, Adib R, Glashan R, et al. 1981. The epidemiology of bladder cancer in West Yorkshire. A preliminary report on non-occupational aetiologies. Carcinogenesis 2:343-347.
60. Cartwright RA, Bernard SM, Glashan RW, et al. 1979b. Bladder cancer amongst dye users. Lancet 2:1073-1074.
61. Cartwright RA, Glashan RW, Rogers HJ, et al. 1982. Role of Nacetyltransferase phenotypes in bladder carcinogenesis: a pharmacogenetic epidemiological approach to bladder cancer. Lancet 2:842-845.
62. Cartwright RA, Philip PA, Rogers HJ, et al. 1984. Genetically determined debrisoquine oxidation capacity in bladder cancer. Carcinogenesis 5:1191-1192.
63. Cascorbi I, Roots I, Brockmoller J. 2001. Association of NAT1 and NAT2 polymorphisms to urinary bladder cancer: significantly reduced risk in subjects with NAT1*10. Cancer Res 61:5051-5056.
64. Case R, Hosker M. 1954a. Tumour of the urinary bladder as an occupational disease in the rubber industry in England and Wales. Br J Ind Med 8:39-50.
65. Case RA, Hosker ME, McDonald DB, et al. 1954b. Tumours of the urinary bladder in workmen engaged in the manufacture and use of certain dyestuff intermediates in the British chemical industry. I. The role of aniline, benzidine, alpha-naphthylamine, and beta-naphthylamine. Br J Ind Med 11:75-104.
66. Castelao JE, Gago-Dominguez M, Yuan JM, et al. 2003. Phenobarbital use and bladder cancer risk. Eur J Epidemiol 18:659-664.
67. Castelao JE, Yuan JM, Gago-Dominguez M, et al. 2003. Carotenoids/vitamin C and smoking-related bladder cancer. Int J Cancer 110:417-423.
68. Castelao JE, Yuan JM, Skipper PL, et al. 2001. Gender-and smoking-related bladder cancer risk. J Natl Cancer Inst 93:538-545.
69. Castelao JE, Yuan JM, Gago-Dominguez M, et al. 2000. Non-steroidal anti-inflammatory drugs and bladder cancer prevention. Br J Cancer 82:1364-1369.
70. Checkoway H, Smith AH, McMichael AJ, et al. 1981. A case-control study of bladder cancer in the United States rubber and tyre industry. Br J Ind Med 38:240-246.
71. Cheever AW. 1978. Schistosomiasis and neoplasia. J Natl Cancer Inst 61:13-18.
72. Chen R, Seaton A. 1998. A meta-analysis of painting exposure and cancer mortality. Cancer Detect Prev 22:533-539.
73. Chen CJ, Chuang YC, Lin TM, et al. 1985. Malignant neoplasms among residents of a blackfoot disease-endemic area in Taiwan: high-arsenic artesian well water and cancers. Cancer Res 45:5895-5899.
74. Chen CJ, Chuang YC, You SL, et al. 1986. A retrospective study on malignant neoplasms of bladder, lung and liver in blackfoot disease endemic area in Taiwan. Br J Cancer 53:399-405.
75. Chen JG. 1990. A cohort study on the cancer experience among workers exposed to benzidine-derived dyes in Shanghai leather-tanning industry. Zhonghua Yu Fang Yi Xue Za Zhi 24:328-331.
76. Chen WC, Wu HC, Hsu CD, et al. 2002. p21 gene codon 31 polymorphism is associated with bladder cancer. Urol Oncol 7:63-66.
77. Chern HD, Romkes-Sparks M, Hu JJ. 1994. Homozygous deleted genotype of glutathione S-transferase M1 increases susceptibility to aggressive bladder cancer. Proc Am Assoc Cancer Res 35:285-288.
78. Chiang HS, Guo HR, Hong CL, et al. 1993. The incidence of bladder cancer in the black foot disease endemic area in Taiwan. Br J Urol 71:274-278.
79. Chiou HY, Chiou ST, Hsu YH, et al. 2001. Incidence of transitional cell carcinoma and arsenic in drinking water: a follow-up study of 8,102 residents in an arseniasis-endemic area in northeastern Taiwan. Am J Epidemiol 153:411-418.
80. Chiou HY, Hsueh YM, Liaw KF, et al. 1995. Incidence of internal cancers and ingested inorganic arsenic: a seven-year follow-up study in Taiwan. Cancer Res 55:1296-1300.
81. Chiu BC, Lynch CF, Cerhan JR, et al. 2001. Cigarette smoking and risk of bladder, pancreas, kidney, and colorectal cancers in Iowa. Ann Epidemiol 11:28-37.
82. Chyou PH, Nomura AM, Stemmermann GN. 1993. A prospective study of diet, smoking, and lower urinary tract cancer. Ann Epidemiol 3:211-216.
83. Ciccone G, Vineis P. 1988. Coffee drinking and bladder cancer. Cancer Lett 41:45-52.
84. Claude J, Kunze E, Frentzel-Beyme R, et al. 1986. Life-style and occupational risk factors in cancer of the lower urinary tract. Am J Epidemiol 124:578-589.
85. Claude JC, Frentzel-Beyme RR, Kunze E. 1988. Occupation and risk of cancer of the lower urinary tract among men. A case-control study. Int J Cancer 41:371-379.
86. Clavel J, Cordier S. 1991. Coffee consumption and bladder cancer risk. Int J Cancer 47:207-212.
87. Clavel J, Cordier S, Boccon-Gibod L, et al. 1989. Tobacco and bladder cancer in males: increased risk for inhalers and smokers of black tobacco. Int J Cancer 44:605-610.
88. Clavel J, Mandereau L, Limasset JC, et al. 1994. Occupational exposure to polycyclic aromatic hydrocarbons and the risk of bladder cancer: a French case-control study. Int J Epidemiol 23:1145-1153.
89. Clemmesen J. 1981. International Commission for Protection against Environmental Mutagens and Carcinogens. Epidemiological studies into the possible carcinogenicity of hair dyes. Mutat Res 87:65-79.
90. Cole P, Hoover R, Friedell GH. 1972. Occupation and cancer of the lower urinary tract. Cancer 29:1250-1260.
91. Cole P, Monson RR, Haning H, et al. 1971. Smoking and cancer of the lower urinary tract. N Engl J Med 284:129-134.
92. Colt JS, Baris D, Stewart P, et al. 2004. Occupation and bladder cancer in a population-based case-control study in New Hampshire. Cancer Causes Control 15:759-769.
93. Coombs LM, Pigott DA, Sweeney E, et al. 1991. Amplification and over-expression of c-erbB-2 in transitional cell carcinoma of the urinary bladder. Br J Cancer 63:601-608.
94. Cordier S, Clavel J, Limasset JC, et al. 1993. Occupational risks of bladder cancer in France: a multicentre case-control study. Int J Epidemiol 22:403-411.
95. Costantini AS, Paci E, Miligi L, et al. 1989. Cancer mortality among workers in the Tuscan tanning industry. Br J Ind Med 46:384-388.
96. Council on Scientific Affairs. 1985. Saccharin. Review of safety issues. Council on Scientific Affairs. JAMA 254:2622-2624.
97. Crump KS, Guess HA. 1982. Drinking water and cancer: review of recent epidemiological findings and assessment of risks. Annu Rev Public Health 3:339-357.
98. Curigliano G, Zhang YJ, Wang LY, et al. 1996. Immunohistochemical quantitation of 4-aminobiphenyl-DNA adducts and p53 nuclear overexpression in T1 bladder cancer of smokers and nonsmokers. Carcinogenesis 17:911-916.
99. Cutler SJ, Young JL Jr, eds. 1975. Third National Cancer Survery: incidence data. NCI Monogr 41:1-454.
100. Cuzick J, Sasieni P, Evans S. 1992. Ingested arsenic, keratoses, and bladder cancer. Am J Epidemiol 136:417-421.
101. D'Avanzo B, La Vecchia C, Franceschi S, et al. 1992. Coffee consumption and bladder cancer risk. Eur J Cancer 28A:1480-1484.
102. D'Avanzo B, La Vecchia C, Negri E, et al. 1995. Attributable risks for bladder cancer in northern Italy. Ann Epidemiol 5:427-431.
103. D'Avanzo B, Negri E, La Vecchia C, et al. 1990. Cigarette smoking and bladder cancer. Eur J Cancer 26:714-718.
104. Daly AK, Thomas DJ, Cooper J, et al. 1993. Homozygous deletion of gene for glutathione S-transferase M1 in bladder cancer. BMJ 307:481-482.
105. De Stefani E, Correa P, Fierro L, et al. 1991. Black tobacco, mate, and bladder cancer. A case-control study from Uruguay. Cancer 67:536-540.
106. Decarli A, Peto J, Piolatto G, et al. 1985. Bladder cancer mortality of workers exposed to aromatic amines: analysis of models of carcinogenesis. Br J Cancer 51:707-712.
107. Decoufle P. 1979. Cancer risks associated with employment in the leather and leather products industry. Arch Environ Health 34:33-37.
108. Decoufle P, Stanislawczyk K, Houten L, et al. 1977. A Retrospective Survey of Cancer in Relation to Occupation. DHEW Publication No. NIOSH. 77178. Washington, DC: U.S. Government Printing Office.
109. Delzell E, Macaluso M, Cole P. 1989. A follow-up study of workers at a dye and resin manufacturing plant. J Occup Med 31:273-278.
110. Delzell E, Monson RR. 1981. Mortality among rubber workers. III. Cause-specific mortality, 1940-1978. J Occup Med 23:677-684.
111. DeMarini DM, Brooks LR, Bhatnagar VK, et al. 1997a. Urinary mutagenicity as a biomarker in workers exposed to benzidine: correlation with urinary metabolites and urothelial DNA adducts. Carcinogenesis 18:981-988.
112. DeMarini DM, Hastings SB, Brooks LR, et al. 1997b. Pilot study of free and conjugated urinary mutagenicity during consumption of pan-fried meats: possible modulation by cruciferous vegetables, glutathione S-transferaseM1, and N-acetyltransferase-2. Mutat Res 381:83-96.
113. Derby LE, Jick H. 1996. Acetaminophen and renal and bladder cancer. Epidemiology 7:358-362.
114. Devesa SS, Grauman DJ, Blot WJ, et al. 1999. Atlas of Cancer Mortality in the United States, 1950-94. Washington, DC: US Govt Print Off NIH Publ No. NIH. 99-4564.
115. Dewan A, Chattopadhyay P, Kulkarni PK. 1995. N-acetyltransferase activity-a susceptibility factor in human bladder carcinogenesis. Indian J Cancer 32:15-19.
116. Dolin PJ, Cook-Mozaffari P. 1992. Occupation and bladder cancer: a death-certificate study. Br J Cancer 66:568-578.
117. Dolin PJ, Darby SC, Beral V. 1994. Paraplegia and squamous cell carcinoma of the bladder in young women: findings from a case-control study. Br J Cancer 70:167-168.
118. Donato F, Boffetta P, Fazioli R, et al. 1997. Bladder cancer, tobacco smoking, coffee and alcohol drinking in Brescia, northern Italy. Eur J Epidemiol 13:795-800.
119. Dubrow R, Wegman DH. 1984. Cancer and occupation in Massachusetts: a death certificate study. Am J Ind Med 6:207-230.
120. Dunham LJ, Rabson AS, Stewart HL, et al. 1968. Rates, interview, and pathology study of cancer of the urinary bladder in New Orleans, Louisiana. J Natl Cancer Inst 41:683-709.
121. Edling C, Kling H, Flodin U, et al. 1986. Cancer mortality among leather tanners. Br J Ind Med 43:494-496.
122. Edmonds CJ, Smith T. 1986. The long-term hazards of the treatment of thyroid cancer with radioiodine. Br J Radiol 59:45-51.
123. El Morsi B, Sherif M, el Raziki ES. 1975. Experimental bilharzial squamous metaplasia of the urinary bladder in hamsters. Eur J Cancer 11:199-201.
124. El Rifai W, Kamel D, Larramendy ML, et al. 2000. DNA copy number changes in Schistosoma-associated and non-Schistosoma-associated bladder cancer. Am J Pathol 156:871-878.
125. Elem B, Purohit R. 1983. Carcinoma of the urinary bladder in Zambia. A quantitative estimation of Schistosoma haematobium infection. Br J Urol 55:275-278.
126. Engel LS, Taioli E, Pfeiffer R, et al. 2002. Pooled analysis and meta-analysis of glutathione S-transferase M1 and bladder cancer: a HuGE review. Am J Epidemiol 156:95-109.
127. Engeland A, Andersen A, Haldorsen T, et al. 1996. Smoking habits and risk of cancers other than lung cancer: 28 years' follow-up of 26,000 Norwegian men and women. Cancer Causes Control 7:497-506.
128. Englund A. 1980. Cancer incidence among painters and some allied trades. J Toxicol Environ Health 6:1267-1273.
129. Epstein JI, Amin MB, Reuter VR, et al. 1998. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial transitional cell. neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 22:1435-1448.
130. Esteve A, Sorlie T, Martel-Planche G, et al. 1995. Screening for p53 gene mutations in archived tumors of workers occupationally exposed to carcinogens: examples from analysis of bladder tumors. J Occup Environ Med 37:59-68.
131. Fadl-Elmula I, Kytola S, Leithy ME, et al. 2002. Chromosomal aberrations in benign and malignant bilharzia-associated bladder lesions analyzed by comparative genomic hybridization. BMC Cancer 2:5.
132. Falck K, Grohn P, Sorsa M, et al. 1979. Mutagenicity in urine of nurses handling cytostatic drugs. Lancet 1:1250-1251.
133. Falck K, Sorsa M, Vainio H, et al. 1980. Mutagenicity in urine of workers in rubber industry. Mutat Res 79:45-52.
134. Fan TY, Morrison J, Rounbehler DP, et al. 1977. N-Nitrosodiethanolamine in synthetic cutting fluids: a part-per-hundred impurity. Science 196:70-71.
135. Feng Z, Hu W, Rom WN, et al. 2002. 4-aminobiphenyl is a major etiological agent of human bladder cancer: evidence from its DNA binding spectrum in human p53 gene. Carcinogenesis 23:1721-1727.
136. Ferguson AR. 1911. Associated bilharziosis and primary malignant disease of the urinary bladder with observations in a series of forty cases. J Pathol Bacteriol 16:76-94.
137. Fitzgerald JM, Ramchurren N, Rieger K, et al. 1995. Identification of H-ras mutations in urine sediments complements cytology in the detection of bladder tumors. J Natl Cancer Inst 87:129-133.
138. Fokkens W. 1979. Phenacetin abuse related to bladder cancer. Environ Res 20:192-198.
139. Fraser GE. 1999. Associations between diet and cancer, ischemic heart disease, and all-cause mortality in non-Hispanic white California Seventh-day Adventists. Am J Clin Nutr 70:532S-538S.
140. Fraumeni JF Jr. 1968. Cigarette smoking and cancers of the urinary tract: geographic variation in the United States. J Natl Cancer Inst 41:1205-1211.
141. Fraumeni JF Jr, Scotto J, Dunham LJ. 1971. Coffee-drinking and bladder cancer. Lancet 2:1204.
142. Freedman DM, Cantor KP, Lee NL, et al. 1997. Bladder cancer and drinking water: a population-based case-control study in Washington County, Maryland United States. Cancer Causes Control 8:738-744.
143. Gago-Dominguez M, Bell DA, Watson MA, et al. 2003. Permanent hair dyes and bladder cancer: risk modification by cytochrome P4501A2 and Nacetyltransferases 1 and 2. Carcinogenesis 24:483-489.
144. Gago-Dominguez M, Castelao JE, Yuan JM. 2001a. Use of permanent hair dyes and bladder cancer risk. Int J Cancer 91:575-579.
145. Gago-Dominguez M, Chan KK, Ross RK, et al. 2001b. Permanent Hair Dyes and Bladder Cancer Risk. Int J Cancer 94:905-906.
146. Garabrant DH, Wegman DH. 1984. Cancer mortality among shoe and leather workers in Massachusetts. Am J Ind Med 5:303-314.
147. Garcia R, Gonzalez CA, Agudo A, et al. 1999. High intakes of specific carotenoids and flavonoids does not reduce the risk of bladder cancer. Nutr Cancer 35:212-214.
148. Garcia-Closas M, Malats N, Real FX, et al. Genetic variation in the nucleotide excision repair pathway and bladder cancer risk. Cancer Epidemiol Biomarkers Prev. (In press).
149. Garcia-Closas M, Malats N, Silverman D, et al. 2005. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses. Lancet 366:649-659.
150. Garland M, Morris JS, Stampfer MJ, et al. 1995. Prospective study of toenail selenium levels and cancer among women. J Natl Cancer Inst 87:497-505.
151. Garner RC, Mould AJ, Lindsay-Smith V, et al. 1982. Mutagenic urine from bladder cancer patients [letter]. Lancet 2:389.
152. Gelfand M, Weinberg RW, Castle WM. 1967. Relation between carcinoma of the bladder and infestation with Schistosoma haematobium. Lancet 1:1249-1251.
153. Geoffroy-Perez B, Cordier S. 2001. Fluid consumption and the risk of bladder cancer: results of a multicenter case-control study. Int J Cancer 93:880-887.
154. Gibbs GW. 1985. Mortality of aluminum reduction plant workers, 1950 through 1977. J Occup Med 27:761-770.
155. Golka K, Prior V, Blaszkewicz M, et al. 1996. Occupational history and genetic N-acetyltransferase polymorphism in urothelial cancer patients of Leverkusen, Germany. Scand J Work Environ Health 22:332-338.
156. Gonzalez CA, Errezola M, Izarzugaza I, et al. 1991. Urinary infection, renal lithiasis and bladder cancer in Spain. Eur J Cancer 27:498-500.
157. Gonzalez CA, Lopez-Abente G, Errezola M, et al. 1985. Occupation, tobacco use, coffee, and bladder cancer in the county of Mataro Spain. Cancer 55:2031-2034.
158. Greenblatt MS, Bennett WP, Hollstein M, et al. 1994. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54:4855-4878.
159. Guberan E, Usel M, Raymond L, et al. 1989. Disability, mortality, and incidence of cancer among Geneva painters and electricians: a historical prospective study. Br J Ind Med 46:16-23.
160. Habel LA, Bull SA, Friedman GD. 1998. Barbiturates, smoking, and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 7:1049-1050.
161. Habuchi T, Kinoshita H, Yamada H, et al. 1994. Oncogene amplification in urothelial cancers with p53 gene mutation or MDM2 amplification. J Natl Cancer Inst 86:1331-1335.
162. Habuchi T, Takahashi R, Yamada H, et al. 1993. Influence of cigarette smoking and schistosomiasis on p53 gene mutation in urothelial cancer. Cancer Res 53:3795-3799.
163. Hanke J, Krajewska B. 1990. Acetylation phenotypes and bladder cancer. J Occup Med 32:917-918.
164. Hankey BF, Edwards BK, Ries LA, et al. 1991. Problems in cancer surveillance: delineating in situ and invasive bladder cancer. J Natl Cancer Inst 83:384-385.
165. Hankey B, Myers M. 1987. Black/white differences in bladder cancer survival. J Chron Dis 40:65-73.
166. Harries LW, Stubbins MJ, Forman D, et al. 1997. Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis 18:641-644.
167. Harris AL, Neal DE. 1992. Bladder cancer-field versus clonal origin. N Engl J Med 326:759-761.
168. Hartge P, Harvey EB, Linehan WM, et al. 1990. Unexplained excess risk of bladder cancer in men. J Natl Cancer Inst 82:1636-1640.
169. Hartge P, Hoover R, Altman R, et al. 1982. Use of hair dyes and risk of bladder cancer. Cancer Res 42:4784-4787.
170. Hartge P, Hoover R, Kantor A. 1985. Bladder cancer risk and pipes, cigars, and smokeless tobacco. Cancer 55:901-906.
171. Hartge P, Hoover R, West DW, et al. 1983. Coffee drinking and risk of bladder cancer. J Natl Cancer Inst 70:1021-1026.
172. Hartge P, Silverman D, Hoover R, et al. 1987. Changing cigarette habits and bladder cancer risk: a case-control study. J Natl Cancer Inst 78:1119-1125.
173. Hayes RB, Bi W, Rothman N, et al. 1993. N-acetylation phenotype and genotype risk of bladder cancer in benzidine-exposed workers. Carcinogenesis 14:675-678.
174. Hazra A, Chamberlain RM, Grossman HB, et al. 2003. Death receptor 4 and bladder cancer risk. Cancer Res 63:1157-1159.
175. Hein DW. 1988. Acetylator genotype and arylamine-induced carcinogenesis. Biochim Biophys Acta 948:37-66.
176. Hein DW. 2002. Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis. Mutat Res 506-507:65-77.
177. Helzlsouer KJ, Comstock GW, Morris JS. 1989. Selenium, lycopene, alphatocopherol, beta-carotene, retinol, and subsequent bladder cancer. Cancer Res 49:6144-6148.
178. Henley S, Thun MJ. 2001. Use of Permanent Hair Dyes and Bladder-Cancer Risk. Int J Cancer 94:903-904.
179. Hennekens CH, Speizer FE, Rosner B, et al. 1979. Use of permanent hair dyes and cancer among registered nurses. Lancet 1:1390-1393.
180. Henry SA, Kennaway NM, Kennaway EL. 1931. The incidence of cancer of the bladder and prostate in certain occupations. J Hyg 31:125-137.
181. Hicks RM. 1983. The scientific basis for regarding vitamin A and its analogues as anti-carcinogenic agents. Proc Nutr Soc 42:83-93.
182. Hinder RA, Schmaman A. 1969. Bilharziasis and squamous carcinoma of the bladder. S Afr Med J 43:617-618.
183. Hirvonen A, Nylund L, Kociba P, et al. 1994. Modulation of urinary mutagenicity by genetically determined carcinogen metabolism in smokers (published erratum appears in Carcinogenesis 1994. 15(8):1767). Carcinogenesis 15:813-815.
184. Hoar SK, Hoover R. 1985. Truck driving and bladder cancer mortality in rural New England. J Natl Cancer Inst 74:771-774.
185. Hoover R, Cole P. 1971. Population trends in cigarette smoking and bladder cancer. Am J Epidemiol 94:409-418.
186. Hoover R, Hartge P. 1982. Non-nutritive sweeteners and bladder cancer. Am J Public Health 72:382-383.
187. Hoover RN, Strasser PH. 1980. Artificial sweeteners and human bladder cancer. Preliminary results. Lancet 1:837-840.
188. Hopenhayn-Rich C, Biggs ML, Fuchs A, et al. 1996. Bladder cancer mortality associated with arsenic in drinking water in Argentina. Epidemiology 7:117-124.
189. Hours M, Dananche B, Fevotte J, et al. 1994. Bladder cancer and occupational exposures. Scand J Work Environ Health 20:322-330.
190. Howe GR, Burch JD, Miller AB, et al. 1980. Tobacco use, occupation, coffee, various nutrients, and bladder cancer. J Natl Cancer Inst 64:701-713.
191. Howe GR, Burch JD, Miller AB, et al. 1977. Artificial sweeteners and human bladder cancer. Lancet 2:578-581.
192. Hsieh FI, Pu YS, Chern HD, et al. 1999. Genetic polymorphisms of N-acetyltransferase 1 and 2 and risk of cigarette smoking-related bladder cancer. Br J Cancer 81:537-541.
193. Hussain SP, Harris CC. 1998. Molecular epidemiology of human cancer: contribution of mutation spectra studies of tumor suppressor genes. Cancer Res 58:4023-4037.
194. IARC. 1974. Evaluation of Carcinogenic Risk of Chemicals to Man. Some Aromatic Amines, Hydrazine and Related Substances, N-nitroso Compounds and Miscellaneous Alkylating Agents, Vol 4. Lyon: International Agency for Research on Cancer.
195. IARC. 1980. Evaluation of the Carcinogenic Risk of Chemicals to Humans. Some Pharmaceutical Drugs, Vol. 24. Lyon: International Agency for Research on Cancer.
196. IARC. 1981. Evaluation of the carcinogenic risk of chemicals to humans: Some Antineoplastic and Immunosuppressive Agents, Vol 26. Lyon: International Agency for Research on Cancer.
197. IARC. 1982. Evaluation of the Carcinogenic Risk of Chemicals to Humans. Chemicals, Industrial Processes and Industries Associated with Cancer in Humans, Suppl 4. Lyon: International Agency for Research on Cancer.
198. IARC. 1986. Evaluation of the Carcinogenic Risk of Chemicals to Humans: Tobacco Smoking, Vol 38. Lyon: International Agency for Research on Cancer.
199. IARC. 1987. An updating of selected IARC monographs Volumes 1 to 42, Supply 7, Lyon: International Agency for Research on Cancer.
200. IARC. 1994. Evaluation of Carcinogenic Risks to Humans: Schistosome, Liver flukes and Helicobacter pylori, Vol 61. Lyon: International Agency for Research on Cancer.
201. IARC. 1999. Paracetamol: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Lyon: International Agency for Research on Cancer 73:401-449.
202. Inskip PD, Monson RR, Wagoner JK, et al. 1990. Cancer mortality following radium treatment for uterine bleeding. Radiat Res 123:331-344.
203. Iscovich J, Castelletto R, Esteve J, et al. 1987. Tobacco smoking, occupational exposure and bladder cancer in Argentina. Int J Cancer 40:734-740.
204. Issa JP. 2003. Age-related epigenetic changes and the immune system. Clin Immunol 109:103-108.
205. Jacobs EJ, Henion AK, Briggs PJ, et al. 2002. Vitamin C and vitamin E supplement use and bladder cancer mortality in a large cohort of US men and women. Am J Epidemiol 156:1002-1010.
206. Jemal A, Murray T, Samuels A, et al. 2003. Cancer statistics, 2003. CA Cancer J Clin 53:5-26.
207. Jensen OM, Kamby C. 1982. Intra-uterine exposure to saccharin and risk of bladder cancer in man. Int J Cancer 29:507-509.
208. Jensen OM, Knudsen JB, Sorensen BL, et al. 1983. Artificial sweeteners and absence of bladder cancer risk in Copenhagen. Int J Cancer 32:577-582.
209. Jensen OM, Wahrendorf J, Blettner M, et al. 1987a. The Copenhagen case-control study of bladder cancer: role of smoking in invasive and noninvasive bladder tumours. J Epidemiol Community Health 41:30-36.
210. Jensen OM, Wahrendorf J, Knudsen JB, et al. 1986. The Copenhagen case-control study of bladder cancer II. Effect of coffee and other beverages. Int J Cancer 37:651-657.
211. Jensen OM, Wahrendorf J, Knudsen JB, et al. 1987b. The Copenhagen case-referent study on bladder cancer. Risks among drivers, painters and certain other occupations. Scand J Work Environ Health 13:129-134.
212. Kabat GC, Dieck GS, Wynder EL. 1986. Bladder cancer in nonsmokers. Cancer 57:362-367.
213. Kadlubar FF, Dooley KL, Teitel CH, et al. 1991. Frequency of urination and its effects on metabolism, pharmacokinetics, blood hemoglobin adduct formation, and liver and urinary bladder DNA adduct levels in beagle dogs given the carcinogen 4-aminobiphenyl. Cancer Res 51:4371-4377.
214. Kadlubar FF, Miller JA, Miller EC. 1977. Hepatic microsomal N-glucuronidation and nucleic acid binding of N-hydroxy arylamines in relation to urinary bladder carcinogenesis. Cancer Res 37:805-814.
215. Kadlubar FF, Unruh LE, Flammang TJ, et al. 1981. Alteration of urinary levels of the carcinogen, N-hydroxy-2-naphthylamine, and its N-glucuronide in the rat by control of urinary pH, inhibition of metabolic sulfation, and changes in biliary excretion. Chem Biol Interact 33:129-147.
216. Kahn HA. 1966. The Dorn study of smoking and mortality among U.S. veterans: report on eight and one-half years of observation. Natl Cancer Inst Monogr 19:1-125.
217. Kaldor JM, Day NE, Kittelmann B, et al. 1995. Bladder tumours following chemotherapy and radiotherapy for ovarian cancer: a case-control study. Int J Cancer 63:1-6.
218. Kallioniemi A, Kallioniemi OP, Citro G, et al. 1995. Identification of gains and losses of DNA sequences in primary bladder cancer by comparative genomic hybridization. Genes Chromosomes Cancer 12:213-219.
219. Kannio A, Ridanpaa M, Koskinen H, et al. 1996. A molecular and epidemiological study on bladder cancer: p53 mutations, tobacco smoking, and occupational exposure to asbestos. Cancer Epidemiol Biomarkers Prev 5:33-39.
220. Kantor AF, Hartge P, Hoover RN, et al. 1985. Familial and environmental interactions in bladder cancer risk. Int J Cancer 35:703-706.
221. Kantor AF, Hartge P, Hoover RN, et al. 1984. Urinary tract infection and risk of bladder cancer. Am J Epidemiol 119:510-515.
222. Karagas MR, Tosteson TD, Morris JS, et al. 2004. Incidence of transitional cell carcinoma of the bladder and arsenic exposure in New Hampshire. Cancer Causes Control 15:265-272.
223. Katoh T, Inatomi H, Nagaoka A, et al. 1995. Cytochrome P4501A1 gene polymorphism and homozygous deletion of the glutathione S-transferase M1 gene in urothelial cancer patients. Carcinogenesis 16:655-657.
224. Katoh T, Kaneko S, Takasawa S, et al. 1999. Human glutathione S-transferase P1 polymorphism and susceptibility to smoking related epithelial cancer; oral, lung, gastric, colorectal and urothelial cancer. Pharmacogenetics 9:165-169.
225. Kaye JA, Myers MW. 2001. Acetaminophen and the risk of renal and bladder cancer in the general practice research database. Epidemiology 12:690-694.
226. Kempkes M, Golka K, Reich S, et al. 1996. Glutathione S-transferase GSTM1 and GSTT1 null genotypes as potential risk factors for urothelial cancer of the bladder. Arch Toxicol 71:123-126.
227. Kessler II. 1970. Cancer mortality among diabetics. J Natl Cancer Inst 44:673-686.
228. Kessler II, Clark JP. 1978. Saccharin, cyclamate, and human bladder cancer. No evidence of an association. JAMA 240:349-355.
229. Ketterer B. 1988. Protective role of glutathione and glutathione transferases in mutagenesis and carcinogenesis. Mutat Res 202:343-361.
230. Kiemeney LA, Schoenberg M. 1996. Familial transitional cell carcinoma. J Urol 156:867-872.
231. Kimura F, Florl AR, Seifert HH, et al. 2001. Destabilization of chromosome 9 in transitional cell carcinoma of the urinary bladder. Br J Cancer 85:1887-1893.
232. King WD, Marrett LD. 1996. Case-control study of bladder cancer and chlorination by-products in treated water Ontario, Canada. Cancer Causes Control 7:596-604.
233. Kjaer SK, Knudsen JB, Sorensen BL, et al. 1989. The Copenhagen case-control study of bladder cancer. V. Review of the role of urinary-tract infection. Acta Oncol 28:631-636.
234. Knight A, Askling J, et al. 2002. Cancer incidence in a population-based cohort of patients with Wegener's granulomatosis. Int J Cancer 100:82-85.
235. Knowles MA. 1999. The genetics of transitional cell carcinoma: progress and potential clinical application. BJU Int 84:412-427.
236. Knowles MA, Williamson M. 1993. Mutation of H-ras is infrequent in bladder cancer: confirmation by single-strand conformation polymorphism analysis, designed restriction fragment length polymorphisms, and direct sequencing. Cancer Res 53:133-139.
237. Kogevinas M, Sala M, Boffetta P, et al. 1998. Cancer risk in the rubber industry: a review of the recent epidemiological evidence. Occup Environ Med 55:1-12.
238. Kogevinas M, t'Mannetje A, Cordier S, et al. 2003. Occupation and bladder cancer among men in Western Europe. Cancer Causes Control 14:907-914.
239. Kramer AA, Graham S, Burnett WS, et al. 1991. Familial aggregation of bladder cancer stratified by smoking status. Epidemiology 2:145-148.
240. Kuntz RE, Cheever AW, Myers BJ. 1972. Proliferative epithelial lesions of the urinary bladder of nonhuman primates infected with Schistosoma haematobium. J Natl Cancer Inst 48:223-235.
241. Kunze E, Chang-Claude J, Frentzel-Beyme R. 1992. Life style and occupational risk factors for bladder cancer in Germany. A case-control study. Cancer 69:1776-1790.
242. La Vecchia C, Lucchini F, Negri E, et al. 1999. Urinary bladder cancer death rates in Europe letter. Ann Oncol 10:1529-1530.
243. La Vecchia C, Negri E. 1996. Nutrition and bladder cancer. Cancer Causes Control 7:95-100.
244. La Vecchia C, Negri E, D'Avanzo B, et al. 1990. Occupation and the risk of bladder cancer. Int J Epidemiol 19:264-268.
245. La Vecchia C, Negri E, Decarli A, et al. 1989. Dietary factors in the risk of bladder cancer. Nutr Cancer 12:93-101.
246. La Vecchia C, Tavani A. 1995. Epidemiological evidence on hair dyes and the risk of cancer in humans. Eur J Cancer Prev 4:31-43.
247. Ladero JM, Kwok CK, Jara C, et al. 1985. Hepatic acetylator phenotype in bladder cancer patients. Ann Clin Res 17:96-99.
248. Lafuente A, Pujol F, Carretero P, et al. 1993. Human glutathione S-transferase mu GST mu. deficiency as a marker for the susceptibility to bladder and larynx cancer among smokers. Cancer Lett 68:49-54.
249. Landi MT, Zocchetti C, Bernucci I, et al. 1996. Cytochrome P4501A2: enzyme induction and genetic control in determining 4-aminobiphenylhemoglobin adduct levels. Cancer Epidemiol Biomarkers Prev 5:693-698.
250. LaRue H, Allard P, Simoneau M, et al. 2000. P53 point mutations in initial superficial bladder cancer occur only in tumors from current or recent cigarette smokers. Carcinogenesis 21:101-106.
251. Lee SJ, Cho SH, Park SK, et al. 2002. Combined effect of glutathione Stransferase M1 and T1 genotypes on bladder cancer risk. Cancer Lett 177:173-179.
252. Lee SW, Jang IJ, Shin SG, et al. 1994. CYP1A2 activity as a risk factor for bladder cancer. J Korean Med Sci 9:482-489.
253. Levine LA, Richie JP. 1989. Urological complications of cyclophosphamide. J Urol 141:1063-1069.
254. Lianes P, Orlow I, Zhang ZF, et al. 1994. Altered patterns of MDM2 and TP53 expression in human bladder cancer. J Natl Cancer Inst 86:1325-1330.
255. Lin HJ, Han CY, Bernstein DA, et al. 1994. Ethnic distribution of the glutathione transferase Mu 1-1 GSTM1. null genotype in 1473 individuals and application to bladder cancer susceptibility. Carcinogenesis 15:1077-1081.
256. Lin J, Kadlubar FF, Spitz MR, et al. 2005. A modified host cell reactivation assay to measure DNA repair capacity for removing 4-aminobiphenyl adducts: a pilot study of bladder cancer. Cancer Epidemiol Biomarkers Prev 14:1832-1836.
257. Lockwood K. 1961. On the etiology of bladder tumors in Kobenhavn-Frederiksberg: an inquiry of 369 patients and 369 controls. Acta Path Microbiol Scand 51:1-166.
258. Logan WP. 1982. Cancer mortality by occupation and social class, 1851-1971. IARC Publ No. 36. Lyon: International Agency for Research on Cancer.
259. Lopez-Abente G, Gonzalez CA, Errezola M, et al. 1991. Tobacco smoke inhalation pattern, tobacco type, and bladder cancer in Spain. Am J Epidemiol 134:830-839.
260. Lower GM Jr, Nilsson T, Nelson CE, et al. 1979. N-acetyltransferase phenotype and risk in urinary bladder cancer: approaches in molecular epidemiology. Preliminary results in Sweden and Denmark. Environ Health Perspect 29:71-79.
261. Lunec J, Challen C, Wright C, et al. 1992. c-erbB-2 amplification and identical p53 mutations in concomitant transitional carcinomas of renal pelvis and urinary bladder. Lancet 339:439-440.
262. Lynch CF, Platz CE, Jones MP, et al. 1991. Cancer registry problems in classifying invasive bladder cancer. J Natl Cancer Inst 83:429-433.
263. Maclure M, Bryant MS, Skipper PL, et al. 1990. Decline of the hemoglobin adduct of 4-aminobiphenyl during withdrawal from smoking. Cancer Res 50:181-184.
264. Maffi L, Vineis P. 1986. Occupation and bladder cancer in females. Med Lav 77:511-514.
265. Malaveille C, Vineis P, Esteve J, et al. 1989. Levels of mutagens in the urine of smokers of black and blond tobacco correlate with their risk of bladder cancer. Carcinogenesis 10:577-586.
266. Malker HS, McLaughlin JK, Silverman DT, et al. 1987. Occupational risks for bladder cancer among men in Sweden. Cancer Res 47:6763-6766.
267. Marcus PM, Hayes RB, Vineis P, et al. 2000a. Cigarette smoking, Nacetyltransferase 2 acetylation status, and bladder cancer risk: a case-series meta-analysis of a gene-environment interaction. Cancer Epidemiol Biomarkers Prev 9:461-467.
268. Marcus PM, Vineis P, Rothman N. 2000b. NAT2 slow acetylation and bladder cancer risk: a meta-analysis of 22 case-control studies conducted in the general population. Pharmacogenetics 10:115-122.
269. Markl ID, Cheng J, Liang G, et al. 2001. Global and gene-specific epigenetic patterns in human bladder cancer genomes are relatively stable in vivo and in vitro over time. Cancer Res 61:5875-5884.
270. Marrett LD, Hartge P, Meigs JW. 1986. Bladder cancer and occupational exposure to leather. Br J Ind Med 43:96-100.
271. Martone T, Vineis P, Malaveille C, et al. 2000. Impact of polymorphisms in xenoendo biotic metabolism on pattern and frequency of p53 mutations in bladder cancer. Mutat Res 462:303-309.
272. Maruyama R, Toyooka S, Toyooka KO, et al. 2001. Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological features. Cancer Res 61:8659-8663.
273. Matanoski GM, Elliott EA. 1981. Bladder cancer epidemiology. Epidemiol Rev 3:203-229.
274. Matullo G, Guarrera S, Carturan S, et al. 2001. DNA repair gene polymorphisms, bulky DNA adducts in white blood cells and bladder cancer in a case-control study. Int J Cancer 92:562-567.
275. Matullo G, Guarrera S, Sacerdote C, et al. 2005. Polymorphisms/haplotypes in DNA repair genes and smoking: a bladder cancer case-control study. Cancer Epidemiol Biomarkers Prev 14:2569-2578.
276. McCredie M, Stewart JH. 1988. Does paracetamol cause urothelial cancer or renal papillary necrosis? Nephron 49:296-300.
277. McCredie M, Stewart JH, Ford JM, et al. 1983. Phenacetin-containing analgesics and cancer of the bladder or renal pelvis in women. Br J Urol 55:220-224.
278. McDonald DF, Lund RR. 1954. The role of the urine in vesical neoplasm. 1. Experimental confirmation of the urogenous theory of pathogenesis. J Urol 71:560-570.
279. McGeehin MA, Reif JS, Becher JC, et al. 1993. Case-control study of bladder cancer and water disinfection methods in Colorado. Am J Epidemiol 138:492-501.
280. McLaughlin JK, Zdenek H, Blot WJ, et al. 1995. Smoking and cancer mortality among U.S. veterans: a 26-year follow-up. Int J Cancer 60:190-193.
281. McMichael AJ, Andjelkovic DA, Tyroler HA. 1976. Cancer mortality among rubber workers: an epidemiologic study. Ann N Y Acad Sci 271:125-137.
282. Mee AD. 1982. Aetiological aspects of bladder cancer in urinary bilharzia. Saudi Med J 3:123-128.
283. Meigs JW, Marrett LD, Ulrich FU, et al. 1986. Bladder tumor incidence among workers exposed to benzidine: a thirty-year follow-up. J Natl Cancer Inst 76:1-8.
284. Mellon JK, Lunec J, Wright C, et al. 1996. C-erbB-2 in bladder cancer: molecular biology, correlation with epidermal growth factor receptors and prognostic value. J Urol 155:321-326.
285. Menon MM, Bhide SV. 1984. Mutagenicity of urine of bidi and cigarette smokers and tobacco chewers. Carcinogenesis 5:1523-1524.
286. Mettlin C, Graham S. 1979. Dietary risk factors in human bladder cancer. Am J Epidemiol 110:255-263.
287. Michaud DS, Clinton SK, Rimm EB, et al. 2001. Risk of bladder cancer by geographic region in a U.S. cohort of male health professionals. Epidemiology 12:719-726.
288. Michaud DS, Spiegelman D, Clinton SK, et al. 2000. Prospective study of dietary supplements, macronutrients, micronutrients, and risk of bladder cancer in US men. Am J Epidemiol 152:1145-1153.
289. Michaud DS, Spiegelman D, Clinton SK, et al. 1999a. Fluid intake and the risk of bladder cancer in men. N Engl J Med 340:1390-1397.
290. Michaud DS, Spiegelman D, Clinton SK, et al. 1999b. Fruit and vegetable intake and incidence of bladder cancer in a male prospective cohort. J Natl Cancer Inst 91:605-613.
291. Michaud DS, Wright ME, Cantor KP, et al. 2004. Arsenic concentrations in prediagnostic toenails and the risk of bladder cancer in a cohort study of male smokers. Am J Epidemiol 160:853-859.
292. Mikoczy Z, Schutz A, Hagmar L. 1994. Cancer incidence and mortality among Swedish leather tanners. Occup Environ Med 51:530-535.
293. Milham S Jr. 1976. Occupational mortality in Washington State, 1950-1971. DHEW Publ No. NIOSH. 76175C. Washington, DC, US Govt Print Off.
294. Miller AB, Howe GR. 1977. Artificial sweeteners and bladder cancer. Lancet 2:1221-1222.
295. Miller BA, Silverman DT, Hoover RN, et al. 1986. Cancer risk among artistic painters. Am J Ind Med 9:281-287.
296. Miller CT, Neutel CI, Nair RC, et al. 1978. Relative importance of risk factors in bladder carcinogenesis. J Chronic Dis 31:51-56.
297. Mills PK, Beeson WL, Phillips RL, et al. 1991. Bladder cancer in a low risk population: results from the Adventist Health Study. Am J Epidemiol 133:230-239.
298. Mohtashamipur E, Norpoth K, Lieder F. 1987. Urinary excretion of mutagens in smokers of cigarettes with various tar and nicotine yields, black tobacco, and cigars. Cancer Lett 34:103-112.
299. Momas I, Daures JP, Festy B, et al. 1994a. Bladder cancer and black tobacco cigarette smoking. Some results from a French case-control study. Eur J Epidemiol 10:599-604.
300. Momas I, Daures JP, Festy B, et al. 1994b. Relative importance of risk factors in bladder carcinogenesis: some new results about Mediterranean habits. Cancer Causes Control 5:326-332.
301. Mommsen S, Aagaard J. 1983a. A case-control study of bladder-cancer. A multivariate, stratified analysis of a low-risk population. Dan Med Bull 30:427-432.
302. Mommsen S, Aagaard J, Sell A. 1982. An epidemiological case-control study of bladder cancer in males from a predominantly rural district. Eur J Cancer Clin Oncol 18:1205-1210.
303. Mommsen S, Aagaard J, Sell A. 1983b. A case-control study of female bladder cancer. Eur J Cancer Clin Oncol 19:725-729.
304. Monson RR, Nakano KK. 1976. Mortality among rubber workers. I. White male union employees in Akrob, Ohio. Am J Epidemiol 103:284-296.
305. Montanaro F, Ceppi M, Demers PA, et al. 1997. Mortality in a cohort of tannery workers. Occup Environ Med 54:588-591.
306. Moore LE, Smith AH, Eng C, et al. 2003. P53 alterations in bladder tumors from arsenic and tobacco exposed patients. Carcinogenesis 24:1785-1791.
307. Moore LE, Smith AH, Eng C, et al. 2002. Arsenic-related chromosomal alterations in bladder cancer. J Natl Cancer Inst 94:1688-1696.
308. Moore LE, Smith AH, Hopenhayn-Rich C, et al. 1997. Micronuclei in exfoliated bladder cells among individuals chronically exposed to arsenic in drinking water. Cancer Epidemiol Biomarkers Prev 6:31-36.
309. Morgan RW, Jain MG. 1974. Bladder cancer: smoking, beverages and artificial sweeteners. Can Med Assoc J 111:1067-1070.
310. Morrison AS. 1979. Public health value of using epidemiologic information to identify high-risk groups for bladder cancer screening. Semin Oncol 6:184-188.
311. Morrison AS. 1984a. Control of cigarette smoking in evaluating the association of coffee drinking and bladder cancer. In: Coffee and Health, Banbury Report 17, MacMahon B, Sugimura T (eds.) Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, pp. 127-136.
312. Morrison AS, Ahlbom A, Verhoek WG, et al. 1985. Occupation and bladder cancer in Boston, USA, Manchester, UK, and Nagoya, Japan. J Epidemiol Community Health 39:294-300.
313. Morrison AS, Buring JE. 1980. Artificial sweeteners and cancer of the lower urinary tract. N Engl J Med 302:537-541.
314. Morrison AS, Buring JE, Verhoek WG, et al. 1982a. Coffee drinking and cancer of the lower urinary tract. J Natl Cancer Inst 68:91-94.
315. Morrison AS, Buring JE, Verhoek WG, et al. 1984b. An international study of smoking and bladder cancer. J Urol 131:650-654.
316. Morrison AS, Verhoek WG, Leck I, et al. 1982b. Artificial sweeteners and bladder cancer in Manchester, U.K., and Nagoya, Japan. Br J Cancer 45:332-336.
317. Morton KC, Wang CY, Garner CD, et al. 1981. Carcinogenicity of benzidine, N, N'-diacetylbenzidine, and N-hydroxy-N, N'-diacetylbenzidine for female CD rats. Carcinogenesis 2:747-752.
318. Mostafa MH, Sheweita SA, O'Connor PJ. 1999. Relationship between schistosomiasis and bladder cancer. Clin Microbiol Rev 12:97-111.
319. Murata M, Takayama K, Choi BC, et al. 1996. A nested case-control study on alcohol drinking, tobacco smoking, and cancer. Cancer Detect Prev 20:557-565.
320. Muscheck M, Abol-Enein H, Chew K, et al. 2000. Comparison of genetic changes in schistosome-related transitional and squamous bladder cancers using comparative genomic hybridization. Carcinogenesis 21:1721-1726.
321. Mustacchi P, Shimkin MB. 1985. Cancer of the bladder and infestation with Schistosoma hematobium. J Natl Cancer Inst 20:825-842.
322. Muto S, Horie S, Takahashi S, et al. 2000. Genetic and epigenetic alterations in normal bladder epithelium in patients with metachronous bladder cancer. Cancer Res 60:4021-4025.
323. Myslak ZW, Bolt HM, Brockmann W. 1991. Tumors of the urinary bladder in painters: a case-control study. Am J Ind Med 19:705-713.
324. Nagano J, Kono S, Preston DL, et al. 2000. Bladder-cancer incidence in relation to vegetable and fruit consumption: a prospective study of atomic-bomb survivors. Int J Cancer 86:132-138.
325. Najem GR, Louria DB, Seebode JJ, et al. 1982. Life time occupation, smoking, caffeine, saccharine, hair dyes and bladder carcinogenesis. Int J Epidemiol 11:212-217.
326. National Cancer Institute. 2002. Report of the Kidney/Bladder Cancers Progress Review Group. NIH Publ No. 02-5197. Bethesda, Md: NCI.
327. National Research Council. 1980. Drinking Water and Health. Vol. 3. Washington, DC: Natl Acad Press, 5-21.
328. National Research Council and Subcomittee in Arsenic in Drinking Water. 1999. Arsenic in Drinking Water. Washington, DC, National Academy Press.
329. Negri E, Piolatto G, Pira E, et al. 1989. Cancer mortality in a northern Italian cohort of rubber workers. Br J Ind Med 46:624-628.
330. Nishiyama H, Takahashi T, Kakehi Y, et al. 1999. Homozygous deletion at the 9q32-33 candidate tumor suppressor locus in primary human bladder cancer. Genes Chromosomes Cancer 26:171-175.
331. Nomura AM, Kolonel LN, Hankin JH, et al. 1991. Dietary factors in cancer of the lower urinary tract. Int J Cancer 48:199-205.
332. Nomura A, Kolonel LN, Yoshizawa CN. 1989. Smoking, alcohol, occupation, and hair dye use in cancer of the lower urinary tract. Am J Epidemiol 130:1159-1163.
333. Nomura AM, Stemmermann GN, Heilbrun LK, et al. 1985. Serum vitamin levels and the risk of cancer of specific sites in men of Japanese ancestry in Hawaii. Cancer Res 45:2369-2372.
334. Okkels H, Sigsgaard T, Wolf H, et al. 1997. Arylamine N-acetyltransferase 1 NAT1. and 2 NAT2. polymorphisms in susceptibility to bladder cancer: the influence of smoking. Cancer Epidemiol Biomarkers Prev 6:225-231.
335. Olsen JH, Wallin H, Boice JD Jr, et al. 1993. Phenobarbital, drug metabolism, and human cancer. Cancer Epidemiol Biomarkers Prev 2:449-452.
336. Oyasu R, Hirao Y, Izumi K. 1981. Enhancement by urine of urinary bladder carcinogenesis. Cancer Res 41:478-481.
337. Page WF, Kuntz AJ. 1980. Racial and socioeconomic factors in cancer survival. A comparison of Veterans Administration results with selected studies. Cancer 45:1029-1040.
338. Pannek J. 2002. Transitional cell carcinoma patients with spinal cord injury: a high risk malignancy? Urology 59:240-244.
339. Park SJ, Zhao H, Spitz MR, et al. 2003. An association between NQO1 genetic polymorphism and risk of bladder cancer. Mutat Res 536:131-137.
340. Parkash O, Kiesswetter H. 1976. The role of urine in the etiology of cancer of the urinary bladder. Urol Int 31:343-348.
341. Parkes HG, Veys CA, Waterhouse JA, et al. 1982. Cancer mortality in the British rubber industry. Br J Ind Med 39:209-220.
342. Parkin DM, Bray FI. 2003. International Patterns of Cancer Incidence and Mortality. In: Cancer Epidemiology and Prevention, Schottenfeld D, Fraumeni J (eds).
343. Parkin DM, Whelan SL, Ferlay J, et al. 2002. Cancer Incidence in Five Continents, Vol. VIII. IARC Publ. No. 155. Lyon: International Agency for Research on Cancer.
344. Pashos CL, Botteman MF, Laskin BL, et al. 2002. Bladder cancer: Epidemiology, diagnosis, and management. Cancer Pract 10:311-322.
345. Paterson RF, Ulbright TM, MacLennan GT, et al. 2003. Molecular genetic alterations in the laster-capture-microdissected stroma adjacent to bladder carcinoma. Cancer 98:1830-1836.
346. Pedersen-Bjergaard J, Ersboll J, Hansen VL, et al. 1988. Carcinoma of the urinary bladder after treatment with cyclophosphamide for non-Hodgkin's lymphoma. N Engl J Med 318:1028-1032.
347. Pelucchi C, La Vecchia C, Negri E, et al. 2002a. Smoking and other risk factors for bladder cancer in women. Prev Med 35:114-120.
348. Pelucchi C, Negri E, Franceschi S, et al. 2002b. Alcohol drinking and bladder cancer. J Clin Epidemiol 55:637-641.
349. Peluso M, Airoldi L, Magagnotti C, et al. 2000. White blood cell DNA adducts and fruit and vegetable consumption in bladder cancer. Carcinogenesis 21:183-187.
350. Perneger TV. 2001. Sex, smoking, and cancer: a reappraisal. J Natl Cancer Inst 93:1600-1602.
351. Peters U, Sinha R, Bell DA, et al. 2004. Urinary mutagenesis and fried red meat intake: influence of cooking temperature, phenotype, and genotype of metabolizing enzymes in a controlled feeding study. Environ Mol Mutagen 43:53-74.
352. Piolatto G, Negri E, La Vecchia C, et al. 1991. Bladder cancer mortality of workers exposed to aromatic amines: an updated analysis. Br J Cancer 63:457-459.
353. Piper JM, Matanoski GM, Tonascia J. 1986. Bladder cancer in young women. Am J Epidemiol 123:1033-1042.
354. Piper JM, Tonascia J, Matanoski GM. 1985. Heavy phenacetin use and bladder cancer in women aged 20 to 49 years. N Engl J Med 313:292-295.
355. Pitard A, Brennan P, Clavel J, et al. 2001. Cigar, pipe, and cigarette smoking and bladder cancer risk in European men. Cancer Causes Control 12:551-556.
356. Plna K, Hemminki K. 2001. Familial bladder cancer in the National Swedish Family Cancer Database. J Urol 166:2129-2133.
357. Pohlabeln H, Jockel KH, Bolm-Audorff U. 1999. Non-occupational risk factors for cancer of the lower urinary tract in Germany. Eur J Epidemiol 15:411-419.
358. Pommer W, Bronder E, Klimpel A, et al. 1999. Urothelial cancer at different tumour sites: role of smoking and habitual intake of analgesics and laxatives. Results of the Berlin Urothelial Cancer Study. Nephrol Dial Transplant 14:2892-2897.
359. Popp W, Schmieding W, Speck M, et al. 1992. Incidence of bladder cancer in a cohort of workers exposed to 4-chloro-o-toluidine while synthesising chlordimeform. Br J Ind Med 49:529-531.
360. Porru S, Aulenti V, Donato F, et al. 1996. Bladder cancer and occupation: a case-control study in northern Italy. Occup Environ Med 53:6-10.
361. Preston DL, Shimizu Y, Pierce DA, et al. 2003. Studies of mortality of atomic bomb survivors. Report 13: Solid cancer and noncancer disease mortality: 1950-1997. Radiat Res 160:381-407.
362. Probst-Hensch NM, Bell DA, Watson MA, et al. 2000. N-acetyltransferase 2 phenotype but not NAT1*10 genotype affects aminobiphenylhemoglobin adduct levels. Cancer Epidemiol Biomarkers Prev 9:619-623.
363. Proctor AJ, Coombs LM, Cairns JP, et al. 1991. Amplification at chromosome 11q13 in transitional cell tumours of the bladder. Oncogene 6:789-795.
364. Prout GR Jr, Wesley MN, Greenberg RS, et al. 2000. Bladder cancer: race differences in extent of disease at diagnosis. Cancer 89:1349-1358.
365. Puente D, Hartge P, Greiser E, et al. 2006. A pooled analysis of bladder cancer casecontrol studies evaluating smoking in men and women. Cancer Causes Control 17:71-79.
366. Pujolar AE, Gonzalez CA, Lopez-Abente G, et al. 1993. Bladder cancer and coffee consumption in smokers and nonsmokers in Spain. Int J Epidemiol 22:38-44.
367. Puntoni R, Bolognesi C, Bonassi S, et al. 1988. Cancer risk evaluation in an area with a high density of chemical plants. An interdisciplinary approach. Ann N Y Acad Sci 534:808-816.
368. Radosauljevic V, Jankavic S, Marinkovic J, Djokic M. 2003. Fluid intake and bladder cancer. A case-control study. Neoplasma 50:234-238.
369. Rebelakos A, Trichopoulos D, Tzonou A, et al. 1985. Tobacco smoking, coffee drinking, and occupation as risk factors for bladder cancer in Greece. J Natl Cancer Inst 75:455-461.
370. Remer T, Manz F. 1995. Potential renal acid load of foods and its influence on urine pH. J Am Diet Assoc 95:791-797.
371. Riboli E, Gonzalez CA, Lopez-Abente G, et al. 1991. Diet and bladder cancer in Spain: a multi-centre case-control study. Int J Cancer 49:214-219.
372. Ries LAG, Eisner MP, Kosary CL, et al. (eds). 2003. SEER Cancer Statistics Review, 1975-2000. Bethesda, MD, National Cancer Institute.
373. Risch A, Wallace DM, Bathers S, et al. 1995. Slow N-acetylation genotype is a susceptibility factor in occupational and smoking related bladder cancer. Hum Mol Genet 4:231-236.
374. Risch HA, Burch JD, Miller AB, et al. 1988a. Dietary factors and the incidence of cancer of the urinary bladder. Am J Epidemiol 127:1179-1191.
375. Risch HA, Burch JD, Miller AB, et al. 1988b. Occupational factors and the incidence of cancer of the bladder in Canada. Br J Ind Med 45:361-367.
376. Rockette HE, Arena VC. 1983. Mortality studies of aluminum reduction plant workers: potroom and carbon department. J Occup Med 25:549-557.
377. Romanenko A, Lee CC, Yamamoto S, et al. 1999. Urinary bladder lesions after the Chernobyl accident: immunohistochemical assessment of p53, proliferating cell nuclear antigen, cyclin D1 and p21WAF1/Cip1. Jpn J Cancer Res 90:144-153.
378. Romanenko A, Morimura K, Wanibuchi H, et al. 2000. Increased oxidative stress with gene alteration in urinary bladder urothelium after the Chernobyl accident. Int J Cancer 86:790-798.
379. Romanenko A, Morimura K, Wanibuchi H, et al. 2003. Urinary bladder lesions induced by persistent chronic low-dose ionizing radiation. Cancer Sci 94:328-333.
380. Romanenko A, Morimura K, Wei M, et al. 2002. DNA damage repair in bladder urothelium after the Chernobyl accident in Ukraine. J Urol 168:973-977.
381. Romano G, Garagnani L, Boninsegna A, et al. 1999. Analysis of 4-ABP-DNA adducts and p53 alterations in urinary bladder carcinoma. Anticancer Res 19:4571-4576.
382. Romundstad P, Andersen A, Haldorsen T. 2000. Cancer incidence among workers in six Norwegian aluminum plants. Scand J Work Environ Health 26:461-269.
383. Ross RK, Jones PA, Yu M. 1996. Bladder cancer epidemiology and pathogenesis. Semin Oncol 23:536-545.
384. Rothman N, Bhatnagar VK, Hayes RB, et al. 1996. The impact of interindividual variation in NAT2 activity on benzidine urinary metabolites and urothelial DNA adducts in exposed workers. Proc Natl Acad Sci 93:5084-5089.
385. Rothman N, Talaska G, Hayes RB, et al. 1997. Acidic urine pH is associated with elevated levels of free urinary benzidine and N-acetylbenzidine and urothelial cell DNA adducts in exposed workers. Cancer Epidemiol Biomarkers Prev 6:1039-1042.
386. Rowland PG, Henneberry MO, Oyasu R, et al. 1980. Effects of urine and continued exposure to carcinogen on progression of early neoplastic urinary bladder lesions. Cancer Res 40:4524-4527.
387. Rubino GF, Scansetti G, Piolatto G, et al. 1982. The carcinogenic effect of aromatic amines: an epidemiological study on the role of o-toluidine and 4,4'-methylene bis 2-methylaniline. in inducing bladder cancer in man. Environ Res 27:241-254.
388. Sala M, Cordier S, Chang-Claude J, et al. 2000. Coffee consumption and bladder cancer in nonsmokers: a pooled analysis of case-control studies in European countries. Cancer Causes Control 11:925-931.
389. Sanchez-Carbayo M, Socci ND, Lozano JJ, et al. 2003. Gene discovery in bladder cancer progression using cDNA microarray. Am J Pathology 163:505-516.
390. Sandler DP, Everson RB, Wilcox AJ. 1985. Passive smoking in adulthood and cancer risk. Am J Epidemiol 121:37-48.
391. Sanyal S, Festa F, Sakano S, et al. 2004. Polymorphisms in DNA repair and metabolic genes in bladder cancer. Carcinogenesis 25:729-734.
392. Sato K, Moriyama M, Mori S, et al. 1992. An immunohistologic evaluation of C-erbB-2 gene product in patients with urinary bladder carcinoma. Cancer 70:2493-2498.
393. Sauter G, Moch H, Moore D, et al. 1993. Heterogeneity of erbB-2 gene amplification in bladder cancer. Cancer Res 53:2199-2203.
394. Schabath MB, Spitz MR, Grossman HB, et al. 2003. Genetic instability in bladder cancer assessed by the comet assay. J Natl Cancer Inst 95:540-547.
395. Schairer C, Hartge P, Hoover RN, et al. 1988. Racial differences in bladder cancer risk: a case-control study. Am J Epidemiol 128:1027-1037.
396. Schifflers E, Jamart J, Renard V. 1987. Tobacco and occupation as risk factors in bladder cancer: a case-control study in southern Belgium. Int J Cancer 39:287-292.
397. Schoenberg JB, Stemhagen A, Mogielnicki AP, et al. 1984. Case-control study of bladder cancer in New Jersey. I. Occupational exposures in white males. J Natl Cancer Inst 72:973-981.
398. Schroeder JC, Conway K, Li Y, et al. 2003. p53 mutations in bladder cancer: evidence for exogenous versus endogenous risk factors. Cancer Res 63:7530-7538.
399. Schulte PA, Ringen K, Hemstreet GP, et al. 1986. Risk factors for bladder cancer in a cohort exposed to aromatic amines. Cancer 58:2156-2162.
400. Schulte PA, Ringen K, Hemstreet GP, et al. 1987. Occupational cancer of the urinary tract. Occup Med 2:85-107.
401. Seidegard J, Vorachek WR, Pero RW, et al. 1988. Hereditary differences in the expression of the human glutathione transferase active on transstilbene oxide are due to a gene deletion. Proc Natl Acad Sci 85:7293-7297.
402. Semenza JC, Weasel LH. 1997. Molecular epidemiology in environmental health: the potential of tumor suppressor gene p53 as a biomarker. Environ Health Perspect 105 Suppl 1:155-163.
403. Shapiro JA, Jacobs EJ, Thun MJ. 2000. Cigar smoking in men and risk of death from tobacco-related cancers. J Natl Cancer Inst 92:333-337.
404. Shibata A, Ohneseit PF, Tsai YC, et al. 1994. Mutational spectrum in the p53 gene in bladder tumors from the endemic area of black foot disease in Taiwan. Carcinogenesis 15:1085-1087.
405. Shin KY, Kong G, Kim WS, et al. 1997. Overexpression of cyclin D1 correlates with early recurrence in superficial bladder cancers. Br J Cancer 1997 75:1788-1792.
406. Sibley K, Cuthbert-Heavens D, Knowles MA. 2001. Loss of heterozygosity at 4p16.3 and mutation of FGFR3 in transitional cell carcinoma. Oncogene 20:686-691.
407. Sidransky D, Frost P, Von Eschenbach A, et al. 1992. Clonal origin bladder cancer. N Engl J Med 326:737-740.
408. Siemiatycki J, Dewar R, Nadon L, et al. 1994. Occupational risk factors for bladder cancer: results from a case-control study in Montreal, Quebec, Canada. Am J Epidemiol 140:1061-1080.
409. Silverman DT, Hoover RN, Albert S, et al. 1983. Occupation and cancer of the lower urinary tract in Detroit. J Natl Cancer Inst 70:237-245.
410. Silverman DT, Hoover RN, Mason TJ, et al. 1986. Motor exhaust-related occupations and bladder cancer. Cancer Res 46:2113-2116.
411. Silverman DT, Levin LI, Hoover RN. 1989a. Occupational risks of bladder cancer in the United States: II Nonwhite men. J Natl Cancer Inst 81:1480-1483.
412. Silverman DT, Levin LI, Hoover RN. 1989b. Occupational risks of bladder cancer in the United States: I. White men. J Natl Cancer Inst 81:1472-1480.
413. Silverman DT, Levin LI, Hoover RN. 1990. Occupational risks of bladder cancer among white women in the United States. Am J Epidemiol 132:453-461.
414. Silverman DT, Morrison AS, Devesa SS. 1996. Bladder Cancer. In: Cancer Epidemiology and Prevention, Schottenfeld D, Fraumeni J (eds). New York: Oxford University Press, pp. 1142-1179.
415. Simon D, Yen S, Cole P. 1975. Coffee drinking and cancer of the lower urinary tract. J Natl Cancer Inst 54:587-591.
416. Simpson J, Roman E, Law G, et al. 1999. Women's occupation and cancer: preliminary analysis of cancer registrations in England and Wales, 1971-1990. Am J Ind Med 36:172-185.
417. Skipper PL, Tannenbaum SR, Ross RK, et al. 2003. Nonsmoking-related arylamine exposure and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 12:503-507.
418. Skov T, Lynge E. 1994. Cancer risk and exposures to carcinogens in hairdressers. Skin Pharmacol 7:94-100.
419. Slattery ML, Schumacher MC, West DW, et al. 1988a. Smoking and bladder cancer. The modifying effect of cigarettes on other factors. Cancer 61:402-408.
420. Slattery ML, West DW, Robison LM. 1988b. Fluid intake and bladder cancer in Utah. Int J Cancer 42:17-22.
421. Smith AH, Goycolea M, Haque R, et al. 1998. Marked increase in baldder and lung cancer mortality in a region of Northern Chile due to arsenic in drinking water. Am J Epidemiol 147:660-669.
422. Sole G, Sorahan T. 1985. Coarse fishing and risk of urothelial cancer. Lancet 1:1477-1479.
423. Soll-Johanning H, Bach E, Olsen JH, et al. 1998. Cancer incidence in urban bus drivers and tramway employees: a retrospective cohort study. Occup Environ Med 55:594-598.
424. Sorahan T, Lancashire RJ, Sole G. 1994. Urothelial cancer and cigarette smoking: findings from a regional case-controlled study. Br J Urol 74:753-756.
425. Sorahan T, Sole G. 1990. Coarse fishing and urothelial cancer: a regional case-control study. Br J Cancer 62:138-141.
426. Sorlie T, Martel-Planche G, Hainaut P, et al. 1998. Analysis of p53, p16MTS, p21WAF1 and H-ras in archived bladder tumours from workers exposed to aromatic amines. Br J Cancer 77:1573-1579.
427. Spinelli JJ, Band PR, Svirchev LM, et al. 1991. Mortality and cancer incidence in aluminum reduction plant workers. J Ocuup Med 33:1150-1155.
428. Spruck CH, Rideout WM, Olumi AF, et al. 1993. Distinct pattern of p53 mutations in bladder cancer: relationship to tobacco. Cancer Res 53:1162-1166.
429. Stasik MJ. 1988. Carcinomas of the urinary bladder in a 4-chloro-o-toluidine cohort. Int Arch Occup Environ Health 60:21-24.
430. Steenland K, Palu S. 1999. Cohort mortality study of 57,000 painters and other union members: a 15 year update. Occup Environ Med 56:315-321.
431. Steenland K, Burnett C, Osorio AM. 1987. A case-control study of bladder cancer using city directories as a source of occupational data. Am J Epidemiol 126:247-257.
432. Steineck G, Hagman U, Gerhardsson M, et al. 1990. Vitamin A supplements, fried foods, fat and urothelial cancer. A case-referent study in Stockholm in 1985-87. Int J Cancer 45:1006-1011.
433. Steineck G, Norell SE, Feychting M. 1988. Diet, tobacco and urothelial cancer. A 14-year follow-up of 16,477 subjects. Acta Oncol 27:323-327.
434. Steineck G, Plato N, Alfredsson L, et al. 1989. Industry-related urothelial carcinogens: application of a job-exposure matrix to census data. Am J Ind Med 16:209-224.
435. Steinmaus CM, Nunez S, Smith AH. 2000. Diet and baldder cancer: a metaanalysis of six dietary variables. AM J Epidemiol 151:693-702.
436. Steinmaus C, Yuan Y, Bates MN, et al. 2003. Case-control study of bladder cancer and drinking water arsenic in the western United States. Am J Epidemiol 158:1193-1201.
437. Stensvold I, Jacobsen BK. 1994. Coffee and cancer: a prospective study of 43,000 Norwegian men and women. Cancer Causes Control 5:401-408.
438. Stern FB, Beaumont JJ, Halperin WE, et al. 1987. Mortality of chrome leather tannery workers and chemical exposures in tanneries. Scand J Work Environ Health 13:108-117.
439. Stern MC, Johnson LR, Bell DA, et al. 2002a. XPD codon 751 polymorphism, metabolism genes, smoking, and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 11:1004-1011.
440. Stern MC, Umbach DM, Lunn RM, et al. 2002b. DNA repair gene XRCC3 codon 241 polymorphism, its interaction with smoking and XRCC1 polymorphisms, and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 11:939-943.
441. Stern MC, Umbach DM, van Gils CH, et al. 2001. DNA repair gene XRCC1 polymorphisms, smoking, and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 10:125-131.
442. Surveillance Research Program, National Cancer Institute. SEER*Stat software version 5.0.19. 2003.
443. Swanson GM, Burns PB. 1995. Cancer incidence among women in the workplace: a study of the association between occupation and industry and 11 cancer sites. J Occup Environ Med 37:282-287.
444. 't Mannetje A, Kogevinas M, Chang-Claude J, et al. 1999. Occupation and bladder cancer in European women. Cancer Causes Control 10:209-217.
445. Takayama S, Sieber SM, Adamson RH, et al. 1998. Long-term feeding of sodium saccharin to nonhuman primates: implications for urinary tract cancer. J Natl Cancer Inst 90:19-25.
446. Talaska G, al Juburi AZ, Kadlubar FF. 1991a. Smoking related carcinogen-DNA adducts in biopsy samples of human urinary bladder: identification of N-deoxyguanosin-8-yl.-4-aminobiphenyl as a major adduct. Proc Natl Acad Sci U S A 88:5350-5354.
447. Talaska G, Schamer M, Casetta G, et al. 1994. Carcinogen-DNA adducts in bladder biopsies and urothelial cells: a risk assessment exercise. Cancer Lett 84:93-97.
448. Talaska G, Schamer M, Skipper P, et al. 1991b. Detection of carcinogen-DNA adducts in exfoliated urothelial cells of cigarette smokers: association with smoking, hemoglobin adducts, and urinary mutagenicity. Cancer Epidemiol Biomarkers Prev 1:61-66.
449. Tawfik HN. 1987. Carcinoma of the urinary bladder associated with schistosomiasis in Egypt: the possible causal relationship. Princess Takamatsu Symp 18:197-209.
450. Taylor JA, Li Y, He M, et al. 1996. p53 mutations in bladder tumors from arylamine-exposed workers. Cancer Res 56:294-298.
451. Taylor JA, Umbach DM, Stephens E, et al. 1998. The role of N-acetylation polymorphisms in smoking-associated bladder cancer: evidence of a gene-gene-exposure three-way interaction. Cancer Res 58:3603-3610.
452. Terstegge CW, Swaen GM, Slangen JJ, et al. 1995. Mortality Patterns among Commercial Painters in The Netherlands. Int J Occup Environ Health 1:303-310.
453. Teschke K, Morgan MS, Checkoway H, et al. 1997. Surveillance of nasal and bladder cancer to locate sources of exposure to occupational carcinogens. Occup Environ Med 54:443-451.
454. Theriault G, De Guire L, Cordier S. 1981. Reducing aluminum: an occupation possibly associated with bladder cancer. Can Med Assoc J 124:419-422, 425.
455. Theriault G, Tremblay C, Cordier S, et al. 1984. Bladder cancer in the aluminium industry. Lancet 1:947-950.
456. Thiede T, Christensen BC. 1969. Bladder tumours induced by chlornaphazine. A five-year follow-up study of chlornaphazine-treated patients with polycythaemia. Acta Med Scand 185:133-137.
457. Thomas DB, Uhl CN, Hartge P. 1983. Bladder cancer and alcoholic beverage consumption. Am J Epidemiol 118:720-727.
458. Thompson DE, Mabuchi K, Ron E, et al. 1994. Cancer incidence in atomic bomb survivors. Part II: Solid tumors, 1958-1987. Radiat Res 137:S17-S67.
459. Tolbert PE. 1997. Oils and cancer. Cancer Causes Control 8:386-405.
460. Toruner GA, Akyerli C, Ucar A, et al. 2001. Polymorphisms of glutathione Stransferase genes GSTM1, GSTP1 and GSTT1 and bladder cancer susceptibility in the Turkish population. Arch Toxicol 75:459-464.
461. Travis LB, Curtis RE, Glimelius B, et al. 1995. Bladder and kidney cancer following cyclophosphamide therapy for non-Hodgkin's lymphoma. J Natl Cancer Inst 87:524-530.
462. Tremblay C, Armstrong B, Theriault G, et al. 1995. Estimation of risk of developing bladder cancer among workers exposed to coal tar pitch volatiles in the primary aluminum industry. Am J Ind Med 27:335-348.
463. Tripathi A, Folsom AR, Anderson KE. 2002. Risk factors for urinary bladder carcinoma in postmenopausal women. The Iowa Women's Health Study. Cancer 95:2316-2323.
464. Tsuda T, Babazono A, Yamamoto E, et al. 1995. Ingested arsenic and internal cancer: a historical cohort study followed for 33 years. Am J Epidemiol 141:198-209.
465. Turesky RJ, Freeman JP, Holland RD, et al. 2003. Identification of amino-biphenyl derivatives in commercial hair dyes. Chem Res Toxicol 16:1162-1173.
466. Tyler HA, Notley RG, Schweitzer FA, et al. 1986. Vitamin A status and bladder cancer. Eur J Surg Oncol 12:35-41.
467. Underwood M, Bartlett J, Reeves J, et al. 1995. C-erbB-2 gene amplification: a molecular marker in recurrent bladder tumors? Cancer Res 55:2422-2430.
468. UNSCEAR. 2000. Sources and Effects of Ionizing Radiation: United Nations Scientific Committee on the Effects of Atomic Radiation 2000 report to the General Assembly, with Scientific Annexes, Vol. II: Effects. New York: United Nations.
469. US Congress, Office of Technology Assessment. 1977. Cancer Testing Technology and Saccharin. Washington, DC: US Govt Print Office.
470. Van Gils CH, Conway K, Li Y, et al. 2002. HRAS1 variable number of tandem repeats polymorphism and risk of bladder cancer. Int J Cancer 100:414-418.
471. Vatsis KP, Martell KJ, Weber WW. 1991. Diverse point mutations in the human gene for polymorphic N-acetyltransferase. Proc Natl Acad Sci U S A 88:6333-6337.
472. Veltman JA, Fridlyand J, Pejavar S, et al. 2003. Array-based comparative genomic hybridization for genome-wide screening of DNA copy number in bladder tumors. Cancer Res 63:2872-2880.
473. Vena JE, Freudenheim J, Graham S, et al. 1993a. Coffee, cigarette smoking, and bladder cancer in western New York. Ann Epidemiol 3:586-591.
474. Vena JE, Graham S, Freudenheim J, et al. 1992. Diet in the epidemiology of bladder cancer in western New York. Nutr Cancer 18:255-264.
475. Vena JE, Graham S, Freudenheim J, et al. 1993b. Drinking water, fluid intake, and bladder cancer in western New York. Arch Environ Health 48:191-198.
476. Villanueva CM, Cantor KP, Cordier S, et al. 2004. Pooled analysis of case-control studies of bladder cancer and disinfection by-products. Epidemiology 15:357-367.
477. Villanueva CM, Fernandez F, Malats N, et al. 2003. Meta-analysis of studies on individual consumption of chlorinated drinking water and bladder cancer. J Epidemiol Community Health 57:166-173.
478. Vineis P, Caporaso N. 1995. Tobacco and cancer: epidemiology and the laboratory. Environ Health Perspect 103:156-160.
479. Vineis P, Caporaso N, Tannenbaum SR, et al. 1990. Acetylation phenotype, carcinogen-hemoglobin adducts, and cigarette smoking. Cancer Res 50:3002-3004.
480. Vineis P, Di Prima S. 1983. Cutting oils and bladder cancer. Scand J Work Environ Health 9:449-450.
481. Vineis P, Esteve J, Hartge P, et al. 1988. Effects of timing and type of tobacco in cigarette-induced bladder cancer. Cancer Res 48:3849-3852.
482. Vineis P, Esteve J, Terracini B. 1984. Bladder cancer and smoking in males: types of cigarettes, age at start, effect of stopping and interaction with occupation. Int J Cancer 34:165-170.
483. Vineis P, Kogevinas M, Simonato L, et al. 2000. Leveling-off of the risk of lung and bladder cancer in heavy smokers: an analysis based on multi-centric case-control studies and a metabolic interpretation. Mutat Res 463:103-110.
484. Vineis P, Magnani C. 1985. Occupation and bladder cancer in males: a case-control study. Int J Cancer 35:599-606.
485. Vineis P, Marinelli D, Autrup H, et al. 2001. Current smoking, occupation, N-acetyltransferase-2 and bladder cancer: a pooled analysis of genotype-based studies. Cancer Epidemiol Biomarkers Prev 10:1249-1252.
486. Vineis P, Martone T. 1996. Molecular epidemiology of bladder cancer. Ann Ist Super Sanita 32:21-27.
487. Vineis P, Pirastu R. 1997. Aromatic amines and cancer. Cancer Causes Control 8:346-355.
488. Vizcaino AP, Parkin DM, Boffetta P, et al. 1994. Bladder cancer: epidemiology and risk factors in Bulawayo, Zimbabwe. Cancer Causes Control 5:517-522.
489. Vriesema JL, Aben KK, Witjes JA, et al. 2001. Superficial and metachronous invasive bladder carcinomas are clonally related. Int J Cancer 93:699-702.
490. Wacholder S, Chanock S, Garcia-Closas M, et al. 2004. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst 96:434-442.
491. Wagoner JK. 1970. Leukemia and Other Malignancies Following Radiation Therapy for Gynecological Disorders. Harvard School of Public Health, Boston.
492. Wakai K, Takashi M, Okamura K, et al. 2000. Foods and nutrients in relation to bladder cancer risk: a case-control study in Aichi Prefecture, Central Japan. Nutr Cancer 38:13-22.
493. Walker AM, Dreyer NA, Friedlander E, et al. 1982. An independent analysis of the National Cancer Institute study on non-nutritive sweeteners and bladder cancer. Am J Public Health 72:376-381.
494. Wallin H, Skipper PL, Tannenbaum SR, et al. 1995. Altered aromatic amine metabolism in epileptic patients treated with phenobarbital. Cancer Epidemiol Biomarkers Prev 4:771-773.
495. Wang L, Habuchi T, Takahashi T, et al. 2002. Cyclin D1 gene polymorphism is associated with an increased risk of urinary bladder cancer. Carcinogenesis 23:257-264.
496. Ward E, Carpenter A, Markowitz S, et al. 1991. Excess number of bladder cancers in workers exposed to ortho-toluidine and aniline. J Natl Cancer Inst 83:501-506.
497. Ward E, Halperin W, Thun M, et al. 1988. Bladder tumors in two young males occupationally exposed to MBOCA. Am J Ind Med 14:267-272.
498. Warner ML, Moore LE, Smith MT, et al. 1994. Increased micronuclei in exfoliated bladder cells of individuals who chronically ingest arseniccontraminated water in Nevada. Cancer Epidemiol Biomarkers Prev 3:583-590.
499. Weber WW. 1987. The acetylator gene and drug response. New York: Oxford University Press Inc.
500. Weber WW, Hein DW, Litwin A, et al. 1983. Relationship of acetylator status to isoniazid toxicity, lupus erythematosus, and bladder cancer. Fed Proc 42:3086-3097.
501. Weiss NS. 1995. Cancer in relation to occupational exposure to perchloroethylene. Cancer Causes Control 6:257-266.
502. Wigle DT. 1977. Bladder cancer: Possible new high-risk occupation. Lancet 2:83-84.
503. Wilkins JR, Comstock GW. 1981. Source of drinking water at home and site-specific cancer incidence in Washington County, Maryland. Am J Epidemiol 114:178-190.
504. Williams RR, Horm JW. 1977. Association of cancer sites with tobacco and alcohol consumption and socioeconomic status of patients: interview study from the Third National Cancer Survey. J Natl Cancer Inst 58:525-547.
505. Woolcott CG, King WD, Marrett LD. 2002. Coffee and tea consumption and cancers of the bladder, colon and rectum. Eur J Cancer Prev 11:137-145.
506. World Cancer Research Fund in association with American Institute for Cancer Research. 1997. Food, Nutrition and the Prevention of Cancer: a global perspective. pp. 338-361.
507. Wright ME, Michaud DS, Pietinen P, et al. 2005. Estimate urine pH and bladder cancer risk in a cohort of male smokers (Finland). Cancer Causes Control 16:1117-1123.
508. Wu MM, Kuo TL, Hwang YH, et al. 1989. Dose-response relation between arsenic concentration in well water and mortality from cancers and vascular diseases. Am J Epidemiol 130:1123-1132.
509. Wu X, Amos CI, Zhu Y, et al. 2003. Telomere dysfunction: a potential cancer predisposition factor. J Natl Cancer Inst 95:1211-1218.
510. Wulfkuhle JD, Liotta LA, Petricoin EF. 2003. Proteomic applications for the early detection of cancer. Nature 3:267-275.
511. Wynder EL, Onderdonk J, Mantel N. 1963. An epidemiological investigation of cancer of the bladder. Cancer 16:1388-1407.
512. Wynder EL, Augustine A, Kabat GC, et al. 1988. Effect of the type of cigarette smoked on bladder cancer risk. Cancer 61:622-627.
513. Wynder EL, Goldsmith R. 1977a. The epidemiology of bladder cancer: a second look. Cancer 40:1246-1268.
514. Wynder EL, Stellman SD. 1977b. Comparative epidemiology of tobacco-related cancers. Cancer Res 37:4608-4622.
515. Yamasaki E, Ames BN. 1977. Concentration of mutagens from urine by absorption with the nonpolar resin XAD-2: cigarette smokers have mutagenic urine. Proc Natl Acad Sci U S A 74:3555-3559.
516. Yamamoto S, Romanenko A, Wei M, et al. 1999. Specific p53 gene mutations in urinary bladder epithelium after the Chernobyl accident. Cancer Res 59:3606-3609.
517. Yasunaga Y, Nakanishi H, Naka N, et al. 1997. Alterations of the p53 gene in occupational bladder cancer in workers exposed to aromatic amines. Lab Invest 77:677-684.
518. Yoshida O, Harada T, Miyagawa M, et al. 1971. Bladder cancer in workers in the dyeing industry. Igaku No Ayumi Japan. 79:421.
519. Young JF, Kadlubar FF. 1982. A pharmacokinetic model to predict exposure of the bladder epithelium to urinary N-hydroxyarylamine carcinogens as a function of urine pH, voiding interval, and resorption. Drug Metab Dispos 10:641-644.
520. Yu MC, Ross RK, Chan KK, et al. 1995. Glutathione S-transferase M1 genotype affects aminobiphenyl-hemoglobin adduct levels in white, black and Asian smokers and nonsmokers. Cancer Epidemiol Biomarkers Prev 4:861-864.
521. Yu MC, Skipper PL, Taghizadeh K, et al. 1994. Acetylator phenotype, aminobiphenyl-hemoglobin adduct levels, and bladder cancer risk in white, black, and Asian men in Los Angeles, California. J Natl Cancer Inst 86:712-716.
522. Zeegers M, Dorant E, Goldbohm R, et al. 2001d. Are coffee, tea, and total fluid consumption associated with bladder cancer risk? Results from the Netherlands Cohort Study. Cancer Causes Control 12:231-238.
523. Zeegers MP, Goldbohm RA, Bode P, et al. 2002a. Prediagnostic toenail selenium and risk of bladder cancer. Cancer Epidemiol Biomarkers Prev 11:1292-1297.
524. Zeegers MP, Goldbohm RA, van den Brandt PA. 2001a. Are retinol, vitamin C, vitamin E, folate and carotenoids intake associated with bladder cancer risk? Results from the Netherlands Cohort Study. Br J Cancer 85:977-983.
525. Zeegers MP, Goldbohm RA, van den Brandt PA. 2002b. A prospective study on active and environmental tobacco smoking and bladder cancer risk The Netherlands. Cancer Causes Control 13:83-90.
526. Zeegers MP, Swaen GM, Kant I, et al. 2001b. Occupational risk factors for male bladder cancer: results from a population based case cohort study in the Netherlands. Occup Environ Med 58:590-596.
527. Zeegers MP, Volovics A, Dorant E, et al. 2001c. Alcohol consumption and bladder cancer risk: results from The Netherlands Cohort Study. Am J Epidemiol 153:38-41.
528. Zenser TV, Lakshmi VM, Rustan TD, et al. 1996. Human N-acetylation of benzidine: role of NAT1 and NAT2. Cancer Res 56:3941-3947.
529. Zhang ZF, Cordon-Cardo C, Rothman N, et al. 1997a. Methodological issues in the use of tumour markers in cancer epidemiology. IARC Sci Publ: 201-213.
530. Zhang ZF, Sarkis AS, Cordon-Cardo C, et al. 1994. Tobacco smoking, occupation, and p53 nuclear overexpression in early stage bladder cancer. Cancer Epidemiol Biomarkers Prev 3:19-24.
531. Zhang ZF, Shu XM, Cordon-Cardo C, et al. 1997b. Cigarette smoking and chromosome 9 alterations in bladder cancer. Cancer Epidemiol Biomarkers Prev 6:321-326.
532. Zheng T, Cantor KP, Zhang Y, et al. 2002. Occupation and bladder cancer: a population-based, case-control study in Iowa. J Occup Environ Med 44:685-691.
533. Zhong S, Wyllie AH, Barnes D, et al. 1993. Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer. Carcinogenesis 14:1821-1824.